{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-26-000048","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2026-07-30T20:09:48+00:00","discovered_at":"2026-07-30T20:11:00.296693+00:00","generated_at":"2026-07-30T20:11:39.386836+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q2 2026: net sales $6.6B (+9.4%), adj EPS $3.69 (+17.9%), narrows FY guidance","bullets":["Q2 net sales $6.6B, up 9.4% reported and 9.0% organic; MedSurg/Neuro +9.2% organic, Orthopaedics +8.6%.","Reported EPS $3.30 (+44.1%), adjusted EPS $3.69 (+17.9%); adjusted operating margin 27.4% (+170 bps).","FY 2026 guidance narrowed: organic sales growth 8.3%-9.3%, adjusted EPS $14.95-$15.10.","CEO cites recovery from cyber incident and strong execution; momentum regained."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-26-000048","json":"https://secwatch.observer/filing/0000310764-26-000048.json","markdown":"https://secwatch.observer/filing/0000310764-26-000048.md","text":"https://secwatch.observer/filing/0000310764-26-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/0000310764-26-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/syk-20260730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:11:39.386836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}